Pfizer works to discover and develop innovative, safe, and effective ways to prevent or treat some of the world's most challenging diseases. We are committed to invest and partner with industry and academia to find new cures to various diseases.
We are committed to the safety of patients who take part in our trials, uphold the highest ethical standards in all of our research initiatives and to build the world's premier biopharmaceutical R&D organization. Together, our aspirations are to deliver unparalleled innovation, the best internal and external science, and industry leading productivity within a vibrant, diverse culture.
Pfizer now has broader and deeper disease area knowledge in our Research Units, increased modality and technology capabilities in our Biotechnology Units, and a new approach that harnesses our combined strengths to find the newest, most innovative and valuable medical solutions. Pfizer possesses the scale, portfolio, talent and capabilities that we believe will unlock new levels of productivity. Drug discovery requires both disease area and technology expertise. Our new model has the breadth and depth of Research Units and Biotechnology Units across R&D that frees us to realize the power and possibilities of these combinations to deliver high impact medicines for patients.
For further information of our research projects, please visit:
Research and Development